Tabula Rasa HealthCare Overview
Valuation check: TRHC's ROE is 78.35%, above the Consumer Staples sector average of 34.13%.
Get informed when a big investor buys or sells
+ Follow78.35%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Tabula Rasa HealthCare (TRHC) currently reports a ROE of 78.35%. That is above the Consumer Staples sector average of 34.13%. Use the charts on this page to explore Tabula Rasa HealthCare's ROE history and peer comparisons.
Tabula Rasa HealthCare's ROE of 78.35% is higher than the Consumer Staples sector average of 34.13%. That is roughly 129.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Tabula Rasa HealthCare's current 78.35% should be judged against Consumer Staples norms (sector average: 34.13%) and against TRHC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 78.35%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Consumer Staples average is 34.13%. From there, open related valuation or income-statement pages for Tabula Rasa HealthCare, and consider following TRHC for alerts when major investors trade the stock.
Tabula Rasa HealthCare is classified in the Consumer Staples sector. On ROE, it currently shows 78.35% versus a sector average near 34.13%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Staples are usually more informative than comparing TRHC with unrelated industries.
